BVI Court of Appeal Clarifies Derivative Actions, Director Indemnities and Shadow Director Status

Published: 2 Oct 2026

On 22 September 2026, the Court of Appeal handed down judgment in the case of Zvi Dekel v Clerkenwell Lifestyle Limited dismissing the appeal against the decision of Mithani J to refuse leave to issue derivative proceedings on behalf of a BVI company.


Mr Dekel, a shareholder of Clerkenwell Lifestyle Limited (“CLL BVI”), a BVI company, sought permission under section 184C of the BVI Business Companies Act to bring derivative proceedings in England and Wales in the name of and on behalf of CLL BVI against several intended defendants arising out of the management and financing of a project to develop property (the “Project”) owned by CLL BVI’s UK subsidiary, Clerkenwell Lifestyle (UK) Limited. The proposed claims included allegations of breaches of fiduciary duties, negligence and improper conduct in the structuring, budgeting, financing and managing of the project. The intended defendants were the de jure directors of CLL BVI, two creditors, the property manager (“RE Capital”), and Mr Leech, the CEO and a co-founder of RE Capital who Mr Dekel alleged was liable as a shadow director of CLL BVI.

At first instance, the learned judge refused leave and dismissed a subsequent application by Mr Dekel to revoke or vary the first order on the basis that he was prepared to offer indemnify CLL BVI against any adverse costs made against it in the potential derivative proceedings. The offer of indemnity was made after the judge had circulated his draft judgment refusing leave.

The Court of Appeal held that Mr Dekel had failed to establish that he could not with reasonable diligence have offered the indemnity at an earlier stage before judgment, and that in any event, the offer of an indemnity was insufficient to cure the defects in Mr Dekel’s case. It upheld the learned judge’s decision that Mr Dekel’s proposed claims, as pleaded and based on the materials before the Court, failed to disclose any realistic prospects of success.  Moreover, the indemnity granted to directors under the company’s articles of association operated as a complete defence to claims falling within scope, including claims brought by the company rather than a third party. Additionally, the Court of Appeal confirmed that the definition of director under the BVI Business Companies Act did not include a shadow director.

Ryan Turner of Maitland Chambers and Tamara Cameron of Appleby (BVI) Limited appeared on behalf of the successful Respondent, CLL BVI.  A copy of the judgment can be found here.

Share
More publications
Website-Code-BVI-1
26 Aug 2026

BVI Court Prevents BVI Company from Redomiciling to Preserve Enforcement Against its Shares

In our article published on 14 November 2025 we addressed an interesting case in which the Court appointed a liquidator to a foreign dissolved company, titled “BVI Court Appoints Liquidators to Foreign Dissolved Company”.  That article referenced a further, related, 2-day hearing that was heard and ultimately determined earlier in the year (on 6 May 2025) in which the Claimants sought to prevent a BVI company from re-domiciling itself to Palestine (the Re-domiciliation Application). This article summarises the key aspects of those Applications.

Appleby-Website-Corporate-Practice
26 Aug 2026

Comparative Analysis of Cayman and BVI Companies as Listing Vehicles

This article provides an in-depth company-law comparison of the advantages and disadvantages of Cayman Islands and BVI companies as listing vehicles, with a view to assisting businesses in selecting the appropriate jurisdiction of incorporation for their listing vehicle.

Website-Code-BVI-2
6 Aug 2026

The Rights of Sanctioned Litigants to access to the Court: Court of Appeal issues Key Decision in the BVI

The Eastern Caribbean Court of Appeal has delivered a significant judgment in AO Alfa-Bank v Kipford Ventures Limited, overturning a stay of proceedings and reinstating a US$142 million freezing injunction. The decision provides important guidance on access to justice, sanctions, and interim relief in the BVI.

JPLs, Directors and Arbitration: Grand Court Clarifies the Scope of Provisional Liquidators' Powers
28 Jul 2026

Drelle Overturned in Latest UK Supreme Court Decision

The United Kingdom Supreme Court in its recent decision in Drelle v Servis-Terminal LLC [2026] UKSC 29 (Drelle SC) has overturned the controversial decision of the English Court of Appeal in Servis-Terminal LLC v Drelle [2025] EWCA Civ 62 (Drelle CA), and in doing so has provided welcome clarity on the effect of unrecognised foreign judgments in cross-border bankruptcy and insolvency contexts. This is likely to have a wide-reaching impact – not only in the UK but also offshore – and particularly in the British Virgin Islands following the recent decision in JJW Hotels & Resorts Holding Inc v Rhodes (BVIHCM2025/0296) (JJW Hotels) (which relied heavily on Drelle CA), and in the Cayman Islands where previous authorities had recognised the ability, in the corporate context, for petitioners to present winding up petitions on the basis of an unrecognised foreign judgment.

Appleby-Website-Technology-and-Innovation
16 Jul 2026

Guide to Blockchain & Crypto-Assets in the British Virgin Islands 2026

The BVI Blockchain & Crypto-Assets 2026 guide provides the latest legal information on the evolution and regulation of these markets, licensing and set-up requirements for businesses, cross-border services, defi considerations, and information on payments and stablecoins, as well as tokenisation and real-world assets.

The Global Website header
30 Jun 2026

The Global - 2026 Q2 Review

The Global sees us share updates and insights from across our network of international offices on the latest legislative news, trends or developments impacting the corporate sector.

Website-Code-BVI
25 May 2026

Back to Basics- Disputes Series

COMPELLING THE INNOCENT: NORWICH PHARMACAL RELIEF IN THE BVI Norwich Pharmacal relief can be a key, strategic tool to assist litigants with early-stage investigation where a BVI company is involved in “wrongdoing” that is the subject of ongoing or prospective litigation either in the BVI or abroad.  A Norwich Pharmacal disclosure order in the BVI is typically made against the registered agent of a “wrongdoer” BVI company, unbeknownst to the company itself, compelling the registered agent to provide information and documentation on the company’s directors, shareholders, ultimate beneficial owners and/or assets.  It is a flexible remedy but it typically enables an applicant party to obtain disclosure to identify the protagonists controlling the “wrongdoer” BVI company and details of its assets necessary in order to pursue their claim or to enforce and execute a judgment. Most frequently, relief is given in aid of foreign proceedings where it is needed to properly plead out a potential claim, to support eventual enforcement of a foreign judgment and/or to obtain or police an injunction.

Appleby-Website-BVI1
27 Apr 2026

Back to Basics - Dispute Series

Winding-Up Petitions in the BVI – A Practical Guide For Creditors Applying to appoint a BVI liquidator is one of the most cost effective and efficient tools available to creditors who want to recover debts or liabilities from BVI companies and is often a go-to strategy where simpler methods of debt collection have failed. Once appointed, a liquidator has a broad range of immediate powers including the ability to take possession and control of all of the company’s assets. In this guide, we highlight the process and the key principles for creditors to consider prior to and during the liquidator appointment process. 

Appleby-Website-Private-Client-and-Trusts-Practice
22 Apr 2026

Regulation, Regulation, Regulation

The article discusses updates to global trust guidance and regulation, as well as beneficial ownership and the regulatory burden on trustees that comes with increased transparency.

Appleby-Website-Corporate-Practice
22 Apr 2026

Prospects of Asian Companies in U.S. Listings in 2026

Nasdaq introduced a series of rule changes in 2025 to raise minimum requirements for public float and offering size for certain new listings.